SurgiQuest closes $19M round

Orange, CT-based SurgiQuest has closed a $19 million round of financing from new and current investors. River Cities Capital Funds led the round, which also included Fletcher Spaght Ventures. Additional investments from CMEA Ventures, California Technology Ventures, Aphelion Medical Fund and other existing SurgiQuest investors completed the round. 

SurgiQuest, which was founded in May 2006, develops, manufactures and markets innovative access technology for minimally invasive surgery. Its AirSeal access system aids access to the abdominal cavity during minimally invasive surgery. Unlike conventional insufflation and trocar systems, the company's platform assures stable pneumoperitoneum, continuously evacuates smoke and plume when energized medical devices such as electrocautery, laser or ultrasound are used, and provides valve-free access to the abdominal cavity during both laparoscopic and robotic surgical procedures.

The company plans to use the money to respond to increasing demand for its products and drive commercialization initiatives worldwide.

- see more from the SurgiQuest release

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.